机译:先进的腔的乳腺癌(激素受体阳性,HER2阴性):新的2015年治疗的选择
Ctr Leon Berard, Dept Med, F-69008 Lyon, France;
Cairo Univ, Teaching Hosp, Dept Clin Oncol, Cairo, Egypt;
mTOR Inhibitor; Insulin-Like Growth Factor Receptor; Molecular Targeted Therapytherapy, endocrinehormone resistancePhenobarbitalReceptor, ErbB-2Breast CancerHormonesCause of Death;
机译:Fulvestrant plus palbociclib in advanced or metastatic hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer after fulvestrant monotherapy: Japan Breast Cancer Research Group-M07 (FUTURE trial)
机译:Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer
机译:Everolimus-based therapy in patients with hormone receptor-positive, HER2(-) advanced breast cancer: management considerations
机译:CDO1 promoter methylation is a Biomarker for Outcome prediction of anthracycline Treated, Estrogen Receptor-positive, Lymph Node-positive Breast Cancer patients